Collaboration and License Agreement - Schedule of Transaction Price Performance Obligations (Details) - Bristol-Myers Squibb Company $ in Thousands |
Mar. 31, 2022
USD ($)
|
---|---|
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |
Transaction price | $ 50,000 |
Research Activities | |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |
Transaction price | 6,405 |
Options to License Druggable Target Lesions | |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |
Transaction price | 31,148 |
Options to License Undruggable Targets | |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |
Transaction price | $ 12,447 |